Detalles de la búsqueda
1.
Same-day initiation of bictegravir/emtricitabine/tenofovir alafenamide: Week 48 results of the FAST study-IMEA 055.
J Antimicrob Chemother
; 78(3): 769-778, 2023 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36659824
2.
Pharmacovirological analyses of blood and male genital compartment in patients receiving dolutegravir + lamivudine dual therapy as a switch strategy (ANRS 167 LAMIDOL trial).
J Antimicrob Chemother
; 75(6): 1611-1617, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32091102
3.
Dolutegravir and lamivudine maintenance therapy in HIV-1 virologically suppressed patients: results of the ANRS 167 trial (LAMIDOL).
J Antimicrob Chemother
; 74(3): 739-745, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30476165
4.
Efficacy and safety of once-daily ritonavir-boosted atazanavir or darunavir in combination with a dual nucleos(t)ide analogue backbone in HIV-1-infected combined ART (cART)-naive patients with severe immunosuppression: a 48 week, non-comparative, randomized, multicentre trial (IMEA 040 DATA trial).
J Antimicrob Chemother
; 71(8): 2252-61, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27068399
5.
Tenofovir plasma concentrations related to estimated glomerular filtration rate changes in first-line regimens in African HIV-infected patients: ANRS 12115 DAYANA substudy.
J Antimicrob Chemother
; 70(5): 1517-21, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25583749
6.
Implementation of an intensive adherence intervention in patients with second-line antiretroviral therapy failure in four west African countries with little access to genotypic resistance testing: a prospective cohort study.
Lancet HIV
; 6(11): e750-e759, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31601544
7.
Evaluation of four tenofovir-containing regimens as first-line treatments in Cameroon and Senegal: the ANRS 12115 DAYANA Trial.
Antivir Ther
; 19(1): 51-9, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-23970206
Resultados
1 -
7
de 7
1
Próxima >
>>